STIM VS MDAI Stock Comparison

Performance

STIM
10/100

STIM returned -72.04% in the last 12 months. Based on SPY's performance of -13.39%, its performance is below average giving it a score of 10 of 100.

MDAI
10/100

MDAI returned -62.12% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

STIM
90/100

5 analysts offer 12-month price targets for STIM. Together, they have an average target of 8, the most optimistic target put STIM at 8 within 12-months and the most pessimistic has STIM at 8.

MDAI

"Analyst Price Targets" not found for MDAI

Sentiment

STIM
74/100

STIM had a bullish sentiment score of 74.22% across Twitter and StockTwits over the last 12 months. It had an average of 3.11 posts, 0.22 comments, and 0.44 likes per day.

MDAI

"Sentiment" not found for MDAI

Technicals

STIM
64/100

STIM receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.

MDAI

"Technicals" not found for MDAI

Earnings

STIM
24/100

STIM has missed earnings 4 times in the last 20 quarters.

MDAI

"Earnings" not found for MDAI

Profit

STIM
10/100

Out of the last 20 quarters, STIM has had 0 profitable quarters and has increased their profits year over year on 0 of them.

MDAI

"Profit" not found for MDAI

Volatility

STIM
33/100

STIM has had a lower than average amount of volatility over the last 12 months giving it a score of 33 of 100.

MDAI
20/100

MDAI has had a lower than average amount of volatility over the last 12 months giving it a score of 20 of 100.

All score calculations are broken down here to help you make more informed investing decisions

Neuronetics, Inc. Common Stock Summary

Nasdaq / STIM

Healthcare

Medical - Diagnostics & Research

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Spectral AI, Inc. Class A Common Stock Summary

Nasdaq / MDAI

Healthcare

Medical - Devices

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

Power up your portfolio